Lux Biosciences is currently conducting one Phase 3 Study to assess the efficacy and safety of voclosporin as therapy in subjects with active noninfectious uveitis. For more information, please follow the link on the ClinicalTrials.gov website: http://www.clinicaltrials.gov/ct2/show/NCT01243983?term=LX211&rank=4

U.S. National Library of Medicine (NLM) and ClinicalTrials.gov